ALCAM and colonic neoplasm: Also, Kanwar et al. [85] reported that difluorinated-curcumin, a novel curcumin analog, together with other chemotherapeutic agents reduced the CSC cell markers CD44 and CD166 in chemo-resistant colon cancer cells.